GEODE CAPITAL MANAGEMENT, LLC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1214717
BOSTON, MA
Position in MDGL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$201,291,815
-$37,342,453 QoQ
Shares Held
374,880
-17.8% QoQ
Ownership
1.62%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. MDGL ranks #25 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in MDGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $201,291,815 | 374,880 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $238,634,268 | 455,870 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $263,068,018 | 451,743 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $204,669,227 | 446,233 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $125,411,594 | 414,392 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $139,406,425 | 420,875 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $126,692,052 | 410,578 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $86,088,103 | 405,655 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $112,023,095 | 399,854 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $92,624,693 | 346,857 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $77,802,681 | 336,255 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $43,291,805 | 296,438 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $62,674,689 | 271,319 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $60,094,288 | 248,057 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $68,668,796 | 236,585 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $14,933,792 | 229,786 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,091,327 | 224,802 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $21,388,982 | 217,988 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $18,644,325 | 220,018 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $16,147,501 | 202,375 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $19,297,310 | 198,104 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $18,106,488 | 154,796 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $15,786,807 | 142,006 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $16,387,826 | 138,026 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $15,717,967 | 138,790 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $9,274,299 | 138,920 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||